These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis. Li J; Guo M; Tian X; Wang X; Yang X; Wu P; Liu C; Xiao Z; Qu Y; Yin Y; Wang C; Zhang Y; Zhu Z; Liu Z; Peng C; Zhu T; Liang Q Med; 2021 Jan; 2(1):99-112.e7. PubMed ID: 32838362 [TBL] [Abstract][Full Text] [Related]
5. RNA-protein interactomes as invaluable resources to study RNA viruses: Insights from SARS CoV-2 studies. Koliński M; Kałużna E; Piwecka M Wiley Interdiscip Rev RNA; 2022 Nov; 13(6):e1727. PubMed ID: 35343064 [TBL] [Abstract][Full Text] [Related]
6. An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity. Zhang Y; Shang L; Zhang J; Liu Y; Jin C; Zhao Y; Lei X; Wang W; Xiao X; Zhang X; Liu Y; Liu L; Zhuang MW; Mi Q; Tian C; Wang J; He F; Wang PH; Wang J Cell Chem Biol; 2022 Jan; 29(1):5-18.e6. PubMed ID: 34672954 [TBL] [Abstract][Full Text] [Related]
7. Open Science Resources for the Mass Spectrometry-Based Analysis of SARS-CoV-2. Bittremieux W; Adams C; Laukens K; Dorrestein PC; Bandeira N J Proteome Res; 2021 Mar; 20(3):1464-1475. PubMed ID: 33605735 [TBL] [Abstract][Full Text] [Related]
8. Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology. Haas P; Muralidharan M; Krogan NJ; Kaake RM; Hüttenhain R J Proteome Res; 2021 Feb; 20(2):1133-1152. PubMed ID: 33464917 [TBL] [Abstract][Full Text] [Related]
9. Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. May DG; Scott KL; Campos AR; Roux KJ Cells; 2020 Apr; 9(5):. PubMed ID: 32344865 [TBL] [Abstract][Full Text] [Related]
10. Host cell membrane proteins located near SARS-CoV-2 spike protein attachment sites are identified using proximity labeling and proteomic analysis. Kotani N; Nakano T; Kuwahara R J Biol Chem; 2022 Nov; 298(11):102500. PubMed ID: 36152751 [TBL] [Abstract][Full Text] [Related]
11. AirID, a novel proximity biotinylation enzyme, for analysis of protein-protein interactions. Kido K; Yamanaka S; Nakano S; Motani K; Shinohara S; Nozawa A; Kosako H; Ito S; Sawasaki T Elife; 2020 May; 9():. PubMed ID: 32391793 [TBL] [Abstract][Full Text] [Related]
12. Characterization and functional interrogation of the SARS-CoV-2 RNA interactome. Labeau A; Fery-Simonian L; Lefevre-Utile A; Pourcelot M; Bonnet-Madin L; Soumelis V; Lotteau V; Vidalain PO; Amara A; Meertens L Cell Rep; 2022 Apr; 39(4):110744. PubMed ID: 35477000 [TBL] [Abstract][Full Text] [Related]
13. COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection. Messina F; Giombini E; Agrati C; Vairo F; Ascoli Bartoli T; Al Moghazi S; Piacentini M; Locatelli F; Kobinger G; Maeurer M; Zumla A; Capobianchi MR; Lauria FN; Ippolito G; J Transl Med; 2020 Jun; 18(1):233. PubMed ID: 32522207 [TBL] [Abstract][Full Text] [Related]
14. Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis. Chen Z; Wang C; Feng X; Nie L; Tang M; Zhang H; Xiong Y; Swisher SK; Srivastava M; Chen J EMBO J; 2021 Sep; 40(17):e107776. PubMed ID: 34232536 [TBL] [Abstract][Full Text] [Related]
15. Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors. Hoffmann HH; Schneider WM; Sánchez-Rivera FJ; Luna JM; Ashbrook AW; Soto-Feliciano YM; Leal AA; Le Pen J; Ricardo-Lax I; Michailidis E; Hao Y; Stenzel AF; Peace A; Allis CD; Lowe SW; MacDonald MR; Poirier JT; Rice CM bioRxiv; 2020 Sep; ():. PubMed ID: 32935098 [TBL] [Abstract][Full Text] [Related]
16. An antibody-based proximity labeling protocol to identify biotinylated interactors of SARS-CoV-2. Shang L; Zhang Y; Liu Y; Jin C; Zhao Y; Zhang J; Wang PH; Wang J STAR Protoc; 2022 Jun; 3(2):101406. PubMed ID: 35611119 [TBL] [Abstract][Full Text] [Related]
17. Network for network concept offers new insights into host- SARS-CoV-2 protein interactions and potential novel targets for developing antiviral drugs. Eskandarzade N; Ghorbani A; Samarfard S; Diaz J; Guzzi PH; Fariborzi N; Tahmasebi A; Izadpanah K Comput Biol Med; 2022 Jul; 146():105575. PubMed ID: 35533462 [TBL] [Abstract][Full Text] [Related]
18. The current landscape of coronavirus-host protein-protein interactions. Perrin-Cocon L; Diaz O; Jacquemin C; Barthel V; Ogire E; Ramière C; André P; Lotteau V; Vidalain PO J Transl Med; 2020 Aug; 18(1):319. PubMed ID: 32811513 [TBL] [Abstract][Full Text] [Related]